NO152606C - Analogifremgangsmaate til fremstilling av nye farmasoeytiske anvendbare 2-imidazolin-1-yl-urinstoff-og amidoforbindelser - Google Patents
Analogifremgangsmaate til fremstilling av nye farmasoeytiske anvendbare 2-imidazolin-1-yl-urinstoff-og amidoforbindelserInfo
- Publication number
- NO152606C NO152606C NO790765A NO790765A NO152606C NO 152606 C NO152606 C NO 152606C NO 790765 A NO790765 A NO 790765A NO 790765 A NO790765 A NO 790765A NO 152606 C NO152606 C NO 152606C
- Authority
- NO
- Norway
- Prior art keywords
- imidazolin
- urine
- preparation
- pharmaceutical use
- new pharmaceutical
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/06—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D233/22—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D233/24—Radicals substituted by nitrogen atoms not forming part of a nitro radical
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH251978 | 1978-03-08 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO790765L NO790765L (no) | 1979-09-11 |
| NO152606B NO152606B (no) | 1985-07-15 |
| NO152606C true NO152606C (no) | 1985-10-23 |
Family
ID=4235609
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO790765A NO152606C (no) | 1978-03-08 | 1979-03-07 | Analogifremgangsmaate til fremstilling av nye farmasoeytiske anvendbare 2-imidazolin-1-yl-urinstoff-og amidoforbindelser |
Country Status (28)
| Country | Link |
|---|---|
| US (2) | US4292429A (pt) |
| EP (1) | EP0004561B1 (pt) |
| JP (1) | JPS54125668A (pt) |
| KR (2) | KR820002098B1 (pt) |
| AR (2) | AR225010A1 (pt) |
| AT (1) | AT364375B (pt) |
| AU (1) | AU531006B2 (pt) |
| CS (1) | CS244656B2 (pt) |
| CY (1) | CY1304A (pt) |
| DD (1) | DD142336A5 (pt) |
| DE (1) | DE2961198D1 (pt) |
| DK (1) | DK95279A (pt) |
| ES (1) | ES478342A1 (pt) |
| FI (1) | FI70708C (pt) |
| GB (1) | GB2016011B (pt) |
| GR (1) | GR71998B (pt) |
| HK (1) | HK80185A (pt) |
| HU (1) | HU182940B (pt) |
| IL (1) | IL56797A (pt) |
| MY (1) | MY8700199A (pt) |
| NO (1) | NO152606C (pt) |
| NZ (1) | NZ189841A (pt) |
| OA (1) | OA06201A (pt) |
| PH (1) | PH16207A (pt) |
| PL (2) | PL123150B1 (pt) |
| PT (1) | PT69314A (pt) |
| SU (2) | SU845779A3 (pt) |
| ZA (1) | ZA791062B (pt) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4338453A (en) | 1980-09-17 | 1982-07-06 | The Upjohn Company | Aminoalkyl-1,2,4-triazoles |
| US4353921A (en) * | 1981-06-19 | 1982-10-12 | Berlex Laboratories, Inc. | Antiarrythmic 1-arylcarbamoylalkyl-2-imidazoline derivatives, composition and method of use |
| DE3213509A1 (de) * | 1982-04-10 | 1983-10-20 | Basf Ag, 6700 Ludwigshafen | N-substituierte imidazol-derivate, ihre herstellung, diese enthaltende arzneimittel und ihre verwendung |
| JPS6133173A (ja) * | 1984-07-25 | 1986-02-17 | Torii Yakuhin Kk | アミジン化合物 |
| JPS62501922A (ja) * | 1984-12-12 | 1987-07-30 | エム・ティー・ディー メディカル テクノロジー アンド ディベロプメント リミテッド | 病室等の装備方法 |
| GB8906198D0 (en) * | 1989-03-17 | 1989-05-04 | Ciba Geigy Ag | Compounds |
| MX2007013683A (es) * | 2005-05-03 | 2007-12-03 | Pharma Mar Sa | Tetrahidropirimidinas antitumorales. |
| FR2901273B1 (fr) * | 2006-05-19 | 2010-12-24 | Anaconda Pharma | Inhibiteurs du virus du papillome humain et les compositions pharmaceutiques les contenant |
| EP2337731B1 (en) | 2008-09-17 | 2015-03-11 | William Kingston | Tideway anchor system |
| HUE041362T2 (pt) | 2010-03-04 | 2019-05-28 | Ea Pharma Co Ltd | |
| EP2543660A4 (en) | 2010-03-04 | 2014-04-30 | Ajinomoto Kk | PROPHYLACTIC OR THERAPEUTIC ACTIVE AGAINST DIABETES OR ADIPOSITAS |
| CN102924380B (zh) * | 2012-11-13 | 2014-12-31 | 齐鲁动物保健品有限公司 | 一种咪唑苯脲的制备方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH234990A (de) * | 1938-05-11 | 1944-10-31 | Chem Ind Basel | Verfahren zur Darstellung eines neuen therapeutisch wirksamen Amidins. |
| GB813525A (en) * | 1956-07-09 | 1959-05-21 | Socony Mobil Oil Co Inc | Fuel oil composition |
| GB1082964A (en) * | 1963-06-25 | 1967-09-13 | Wellcome Found | New substituted imidazolines and their preparation and use |
| US3455940A (en) * | 1965-12-07 | 1969-07-15 | Herbert C Stecker | Certain halo and dihalo n-substituted salicylamides |
| GB1174349A (en) * | 1966-08-25 | 1969-12-17 | Boehringer Sohn Ingelheim | Novel 2-Anilinomethylimidazoline Derivatives and process for the preparation thereof |
| US3846071A (en) * | 1969-02-12 | 1974-11-05 | Petrolite Corp | Process of inhibiting corrosion by treatment with phosphate-cyclic amidine salts |
| NL7415845A (nl) * | 1973-12-26 | 1975-06-30 | Upjohn Co | Werkwijze voor het bevorderen van de productie van endogene prostaglandinen door zoogdieren, alsmede werkwijze ter bereiding van daarbij te gebruiken preparaten. |
| US4088766A (en) * | 1975-06-25 | 1978-05-09 | The Upjohn Company | Urea containing compositions and methods |
| US4233451A (en) * | 1976-05-20 | 1980-11-11 | The Procter & Gamble Company | Process for making imidazolinium salts |
| US4353921A (en) * | 1981-06-19 | 1982-10-12 | Berlex Laboratories, Inc. | Antiarrythmic 1-arylcarbamoylalkyl-2-imidazoline derivatives, composition and method of use |
-
1979
- 1979-02-23 US US06/014,661 patent/US4292429A/en not_active Expired - Lifetime
- 1979-03-05 EP EP79100647A patent/EP0004561B1/de not_active Expired
- 1979-03-05 FI FI790740A patent/FI70708C/fi not_active IP Right Cessation
- 1979-03-05 CS CS791460A patent/CS244656B2/cs unknown
- 1979-03-05 DE DE7979100647T patent/DE2961198D1/de not_active Expired
- 1979-03-06 PL PL1979221681A patent/PL123150B1/pl unknown
- 1979-03-06 ES ES478342A patent/ES478342A1/es not_active Expired
- 1979-03-06 DD DD79211405A patent/DD142336A5/de unknown
- 1979-03-06 OA OA56752A patent/OA06201A/xx unknown
- 1979-03-06 KR KR7900682A patent/KR820002098B1/ko active
- 1979-03-06 PL PL1979213924A patent/PL116762B1/pl unknown
- 1979-03-06 IL IL56797A patent/IL56797A/xx unknown
- 1979-03-07 GB GB7908098A patent/GB2016011B/en not_active Expired
- 1979-03-07 HU HU79CI1920A patent/HU182940B/hu unknown
- 1979-03-07 AT AT0171079A patent/AT364375B/de not_active IP Right Cessation
- 1979-03-07 AU AU44900/79A patent/AU531006B2/en not_active Ceased
- 1979-03-07 PT PT69314A patent/PT69314A/pt unknown
- 1979-03-07 DK DK95279A patent/DK95279A/da not_active Application Discontinuation
- 1979-03-07 GR GR58542A patent/GR71998B/el unknown
- 1979-03-07 PH PH22264A patent/PH16207A/en unknown
- 1979-03-07 SU SU792733999A patent/SU845779A3/ru active
- 1979-03-07 NO NO790765A patent/NO152606C/no unknown
- 1979-03-07 NZ NZ189841A patent/NZ189841A/xx unknown
- 1979-03-07 ZA ZA791062A patent/ZA791062B/xx unknown
- 1979-03-07 CY CY1304A patent/CY1304A/xx unknown
- 1979-03-08 JP JP2624579A patent/JPS54125668A/ja active Granted
- 1979-03-18 AR AR275744A patent/AR225010A1/es active
-
1980
- 1980-01-18 SU SU802872253A patent/SU923367A3/ru active
- 1980-07-17 AR AR281806A patent/AR227286A1/es active
-
1981
- 1981-03-25 US US06/247,427 patent/US4420619A/en not_active Expired - Fee Related
-
1982
- 1982-09-08 KR KR1019820004065A patent/KR830000884B1/ko active
-
1985
- 1985-10-17 HK HK801/85A patent/HK80185A/xx unknown
-
1987
- 1987-12-30 MY MY199/87A patent/MY8700199A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO801014L (no) | Fremgangsmaate for fremstilling av nye piperidinderivater | |
| NO151362C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive urinstoffderivater. | |
| NO152635C (no) | Fremgangsmaate for fremstilling av cyklosporinholdige farmasoeytiske preparater i flytende form | |
| NO155774C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazo-diazepin-derivater. | |
| NO151546C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrimidoner | |
| NO148925C (no) | Analogifremgangsmaate til fremstilling av 5-metyl-isoksazol-4-karboksylsyre-(4-trifluormetyl)-anilid med antiflogistisk og antireumatisk virkning | |
| NO150760C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive aminotiazoler. | |
| SE7809789L (sv) | Material for reversibel fixering av biologiska makromolekyler, framstellning och anvendning derav | |
| FI794006A (fi) | Farmaceutiskt preparat omfattande en hjaertglykosid i kombination med en polymer | |
| NO147986C (no) | Analogifremgangsmaate for fremstilling av fysiologisk aktive fenyletylaminer | |
| NO152606C (no) | Analogifremgangsmaate til fremstilling av nye farmasoeytiske anvendbare 2-imidazolin-1-yl-urinstoff-og amidoforbindelser | |
| NO148802C (no) | Fremgangsmaate og belegningspreparat for fremstilling av biologisk aktive preparater med regulert frigjoerelse av aktive bestanddeler | |
| NO150202C (no) | Analogifremgangsmaate til fremstilling av nye terapeutisk virksomme n-oksacyklyl-alkyl-piperidyl-diazaforbindelser | |
| IT7950267A0 (it) | Amminoglucosidi loro preparazione eloro applicazione come medicamenti | |
| NO151319C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive beta-mono-fluormetyl-beta-alanin- og beta-difluormetyl-beta-alanin-forbindelser | |
| NO790523L (no) | Analogifremgangsmaate for fremstilling av farmasoeytisk aktive 2-fenyliminoimidazolidiner | |
| IT7950138A0 (it) | Composizione farmaceutica per il trattamento dei parkinsonismi | |
| NO146204C (no) | Fremgangsmaate til fremstilling av biologisk aktive polymerer | |
| SE7910300L (sv) | Farmaceptisk komposition for behandling av neoplastiska sjukdomar och forfarande for dess framstellning | |
| BR7900354A (pt) | Derivados de acido fenoxi-fenoxi-alcanocarboxilico com efeito herbicida,sua preparacao,composicao contendo os mesmos e seu emprego | |
| NO145843C (no) | Analogifremgangsmaate til fremstilling av terapeutisk virksomme n1-glukofuranosid-6-yl-n3-nitroso-urinstoffer | |
| NO152128C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2-amino-3-benzoylfenylacetamider | |
| NO146863C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive alkyltiofenoksyalkylaminer | |
| NO782707L (no) | Fremgangsmaate for fremstilling av nye 2-pyridyl- og 2-pyrimidylaminobenzoesyrer | |
| NO149314C (no) | Analogifremgangsmaate for fremstilling av fysiologisk aktive imidazoisokinolindioner |